Trial Profile
DD-723 Phase III Clinical Trial - Confirmatory Study in Subjects with Suspected Prostate Cancer -
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Jun 2016
Price :
$35
*
At a glance
- Drugs Perflubutane (Primary)
- Indications Prostate cancer
- Focus Diagnostic use
- Sponsors Daiichi Sankyo Company
- 03 Jun 2016 New trial record